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Serum transferrin precipitated with specific antisera was analyzed by matrix-assisted laser 
desorption ionization/time-of-flight mass spectrometry (MALDI/TOF-MS) and electrospray 
ionization-mass spectrometry (ESI-MS). When analyzed by MALDI, transferrin showed 
signal peaks that clearly could be separated from ions of IgG present in the immunoprecipi- 
tate. By ESI-MS, when the immunoprecipitates were loaded through a microcapillary poly- 
meric reversed-phase column connected to the electrospray ionization probe, the mass 
spectra of transferrin were observed with a high signal-to-noise ratio and good resolution. By 
MALDI/TOF-MS, the observed molecular weight of normal transferrin was ~ 1.2 ku 
smaller when analyzed in the reflectron mode than in the linear mode. The observed 
molecular weight of transferrin treated with sialidase was approximately the same in both 
modes. A comparison between the results obtained in both modes may help to estimate the 
number of sialic acids on the protein molecule. A transferrin isoform with a molecular 
weight of ~ 2.2 ku less than the normal species was identified in the serum of patients with 
a carbohydrate-deficient glycoprotein syndrome as well as in heavy alcohol consumers. (J Am 
Soc Mass Spectrom 1995, 6, 854-859) 
ecent developments in mass spectrometry with 
matrix-assisted laser desorption ionization 
MALDI) and electrospray ionization (ESI) allow 
the accurate molecular mass determination of proteins 
at the low picomole level [1, 2]. For clinical purposes 
protein variants have been identified by electrophore- 
sis, but variants with the same electric charge as 
the native protein cannot be identified. Identification 
of the variants usually requires a complex and time- 
consuming type of chemical analysis. However, by use 
of the above-mentioned recent mass spectrometry 
methods, identification is possible directly with the 
intact macromolecule. To apply these strategies for 
clinical diagnosis, simple and reliable methods of sam- 
ple preparation are desired. 
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As the first test for the accessibility of such mass 
spectrometry methods for clinical diagnosis, an abnor- 
mal transferrin isoform, which is present in the serum 
of patients with carbohydrate-deficient glycoprotein 
(CDG) syndrome [3] as well as in high alcohol con- 
sumers [4, 5], was analyzed by ESI and MALDI. The 
syndrome, a multisystem disorder that affects the ner- 
vous system, was first reported by Jaeken et al. [3]. The 
biochemical feature of the syndrome is an abnormal 
carbohydrate structure of glycoproteins. Normal trans- 
ferrin mainly has a single isoform that contains two 
asparagine N-linked disialylated biantennary carbohy- 
drate chains. Wada et al. [6] and Yamashita et al. [7, 8] 
reported that the abnormal species of CDG syndrome 
transferrin lack either or both of these disialylated 
biantennary carbohydrate chains, as judged by conven- 
tional chemical methods [7] and by electrospray ion- 
ization mass spectrometry (ESI-MS) [6, 8]. Nakanishi et 
al. [9] and Wada et al. [10] also confirmed the molecu- 
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lar weight difference by MALDI. The transferrin from 
CDG patients consists of an isoform of normal size and 
two isoforms with a 2.2 and 4.4 ku lower molecular 
weight. 
The most common method to prepare serum pro- 
teins for such mass spectrometry analysis used to be 
affinity chromatography with an immobilized specific 
antibody. In a preliminary report, we described a new 
method that is suitable for clinical laboratory tests [9], 
whereby serum transferrin (~ 300 mg/dL,  38 nM in 
serum) was precipitated with specific anfisera and 
analyzed by MALDI. Ion signals of the transferrin and 
the antibody included in the immunoprecipitate could 
be separated clearly and were not superimposed in the 
obtained mass spectra. In the present work we ana- 
lyzed the serum proteins precipitated similarly with a 
specific antibody by ESI-MS that is expected to allow a 
more precise analysis. Instead of conventional infusion 
sample loading methods, we loaded the immunopre- 
cipitate through a microcapillary polymeric reversed- 
phase column connected to the ESI probe. 
For glycopeptides that incorporate sialic acids, ions 
generated by MALDI are extremely unstable and split 
off the sialic acids after a certain lifetime [11, 12]. To 
investigate this "metastability" for a large glycopro- 
tein with a greater degree of freedom like transferrin, 
we have analyzed native and sialidase-treated transfer- 
rin ions in different modes of operation of the time-of- 
flight mass spectrometer. Additionally, the carbohy- 
drate-deficient ransferrin was studied again by 
MALDI with special attention to the sialic acids. 
Experimental 
Materials 
Serum was obtained from normal healthy persons, 
from two patients with CDG syndrome in the same 
family [13] and from heavy alcohol drinkers, who 
consumed more than 100-g alcohol per day. The ve- 
nous blood obtained without anticoagulant was al- 
lowed to stand at room temperature until it clotted 
and then was centrifuged at 2100g for 10 min. The 
supernatant was obtained. 
Transferrin was prepared by affinity chromatogra- 
phy [7] and the immunoprecipitafion method. The 
immunoprecipitation method was described in a pre- 
vious report [9]. Briefly, test serum was mixed with 
antitransferrin serum (polyclonal rabbit serum pur- 
chased from Hoechst Japan Ltd. Tokyo; Lot No. 
153443B) and ethylenediaminetetraacetic acid (EDTA) 
was added to give a final concentration f 2.5 mM; the 
serum was kept at 4 °C overnight. The precipitate was 
centrifuged and washed three times with saline fol- 
lowed by five washes with distilled water. The precipi- 
tate was then dissolved in methanol-water (1:1) that 
contained 1% acetic acid. The serum concentration of
transferrin was estimated by a nephelometric assay 
with an antitransferrin antibody. The transferrin con- 
tent in serum was ~ 300 mg/dL,  which is ~ 4% of 
total protein and is ~ 1/16 of albumin. The required 
ratio of test serum and antiserum is dependent on the 
titer of antiserum. There is a broad acceptable range to 
this ratio to allow mass spectrometric detection of the 
target protein. With the lot of antiserum we used in 
the present experiment, good ion peaks of the transfer- 
rin were observed at a ratio of test serum to antiserum 
of 1:1. The amount of test serum and antiserum could 
be reduced. When we used 50 /~L of each serum, 
1/400 of the precipitate was applied on the time-of- 
flight (TOF) mass spectrometer and 1/30 on the micro- 
capillary liquid chromatography (LC) ESI mass spec- 
trometer. Commercially purchased transferrin (Sigma 
Chemical Co., St. Louis, MO) also was used. 
Mass Spectrometry and Microcapillary High 
Performance Liquid Chromatography 
MALDI/TOF mass spectra were recorded on a JMS- 
LDI 1700 (linear mode; JEOL Ltd., Tokyo, Japan) and a 
Vision 2000 (reflectron and linear type; Finnigan MAT, 
Bremen, Germany). Detailed descriptions of the instru- 
ments can be found elsewhere [14, 15]. The matrices 
used were 2,5-dihydroxybenzoic a id and sinapinic 
acid (Aldrich Chemical Co., Milwaukee, W1). The ap- 
plied amount of protein sample for each analysis was 
0.5-2 pmol. 
ESI mass spectra were obtained on a TSQ-7000 triple 
quadrupole mass spectrometer (Finnigan MAT, San 
Jose, CA) equipped with an electrospray ion source 
and a polymeric reversed-phase microcapillary high 
performance liquid chromatography (HPLC) column 
(PLRP-S, 1 mm x 50 ram, 1000 A, 8 /.~m; Michrom 
Bioresources Inc., Pleasanton, CA). The proteins in the 
immunoprecipitates were eluted with a gradient of 
0.2-86% acetonitrile containing 2% acetic acid over 15 
min at a flow rate of 50 ~L/min.  In some cases, 
methanol was used instead of acetonitrile. The applied 
amount of transferrin for each analysis was 10 ~L of 
~ 20-pmol//zL solution. The signal peaks were de- 
tected by using a cell inserted between the column and 
the mass spectrometer. ESI scanning was performed 
m/z 2000 to 4000 in 5 s for a high mass range and m/z 
500 to 2500 in 5 s for a low mass range. Calibration 
was performed by using the multiply-charged ions 
from a separate introduction of horse heart myoglobin 
and hen eggwhite lysozyme. 
Transferrin was treated with sialidase (Sigma 
Chemical Co.) in 0.05-M citrate buffer, pH 5.5, for 24 h 
at an enzyme to transferrin ratio of 4 mu/nmol .  
Results 
Figure 1 shows the analysis of transferrin prepared 
from a healthy individual (Figure la) and from a 
patient with CDG (Figure lb) by immunoprecipitation 
via ESI-MS connected with a microcapillary HPLC. 
Figure insets represent chromatograms of the separa- 
tion of the transferrin-anfibody mixture by HPLC. In 
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F igure  1. Analysis of transferrin prepared by immunoprecipita- 
[*ion via ESI-MS connected to a microcapil(ary HPLC. Chro- 
matograms monitored by UV absorption at 254 nm are presented 
in the insets. Mass spectra of the peaks, marked by horizontal 
bars on the chromatograms, show the multiply charged ions of 
transferrin. Spectra are from a healthy control (a) and from a 
patient with CDG (b). Analyses used a Finnigan MAT TSQ-7000 
triple quadrupole mass spectrometer coupledowith an ultrafast 
microprotein analyzer. Column: PLPR-S (1000 A, 8 /~m, 1 mm x 
50 mm); flow rate: 50 /~L/min; linear gradient from 10% B to 
95% B in 15 min. A = methanol-water (2:98) and 2% acetic acid; 
B = methanol-water (90:10) and 2% acetic acid. 
the corresponding mass spectra of the peaks (marked 
by horizontal bars), the signals of the different multi- 
ply charged transferrin ions were resolved clearly (Fig- 
ure la and b). Multiply charged ion peaks of the main 
component yielded reasonable molecular weight esti- 
mations of normal transferrin i  both spectra (Table 1). 
In the spectra of patient ransferrin (Figure lb) a series 
of ion peaks of the subcomponent (marked by aster- 
isks) were observed between the ion peaks of the main 
component. The spectra of a normal control (Figure la) 
showed no such subcomponent. Figure 2 shows sec- 
tions of MALDI/TOF (LDI-1700) mass spectra in the 
region of the singly charged transferrin ion. Parts (a) 
and (b) represent the results from a normal control. For 
part (a) the sample was purified by affinity chromatog- 
raphy; for part (b) it was prepared by immunoprecipi- 
tation. Therefore, compared to Figure 2a, in Figure 2b 
an additional doubly charged ion signal of IgG is 
observed. Parts (c) and (d) show the spectra of trans- 
ferrin from a heavy alcohol drinker and a CDG patient, 
respectively, with sample preparation by immunopre- 
cipitation. Here, an additional ion signal appears as a 
shoulder on the low mass side of the normal transfer- 
rin signal. These shoulders (marked by arrows) cannot 
Table 1. Observed molecular weights of intact, desialylated, and carbohydrate-deficient 
transferrin measured by MALDI/TOF and ESI mass spectrometry and theoretical molecular 
weights of each form 
Intact normal Desial. normal Difference a Intact CDG 
Theor. MW 79,555.26 78,390.18 
TSQ-7000 (ESI) 79,557 b 78,384 
Vision 2000 c 78,535 + 127 78,483 + 30 
(MALDI reflectron) (3) (3) 
JMS-LD117000 79,710 + 300 78,442 + 230 
(MALDI linear) (5) (3) 
Difference 
between linear 1,175 -41  
and reflectron d
1165.08 77,349.08 
1173 77,354 
52 76,693 
1268 77,485 + 260 
(5) 
792 
a Difference between molecular weight of intact and desialylated normal transferrin (intact - desialy- 
lated). 
b Standard deviation of each analysis by TSQ-7000 was less than 10. 
tEach value is the mean value and standard deviation of analyses. The number of measurements is 
shown in parentheses. 
dDifference between molecular weight observed by linear mode and reflectron mode MALDI/TOF 
mass spectrometry (linear - reflectron). 
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F igure  2. MALDI/TOF mass spectra of transferrin purified by 
affinity chromatography (a) and by immunoprecipitation (b-d). 
(a, b) normal control; (c) alcohol hard drinker; (d) CDG patient. 
Analyses used a JMS-LDI 1700. Arrows show additional ions on 
the low mass/charge shoulder of normal transferrin that are not 
seen in the control spectra. 
be seen in the upper two control spectra. Similar spec- 
tra were observed in all analyzed samples of five 
heavy drinkers. In Figure 3, the MALDI/TOF mass 
spectra of the transferrin-antibody mixture from a 
CDG patient obtained with a linear type (LDI 1700) 
and a reflectron-type instrument (Vision 2000) are 
compared. Again, the region of the singly charged ion 
signal of transferrin is shown. In both cases, the shoul- 
der on the low mass side of the normal transferrin 
signal that corresponds to the carbohydrate-deficient 
species is observed. However, a comparison between 
the obtained absolute molecular weights of the trans- 
ferrin revealed reproducibly smaller values for both 
species in the reflectron than in the linear mode. More- 
over, the molecular weights were much closer to the 
theoretical values in the linear mode. 
in the next step, transferrin was treated with siali- 
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Figure 3. MALDI/TOF mass spectra of transferrin from a pa- 
tient with CDG, analyzed by (a) linear type (LDI 1700) and (b) 
reflectron type MALDI/TOF mass spectrometry (Vision 2000). 
The region of the singly charged ion of transferrin is shown. The 
peak with the arrow is derived from carbohydrate-deficient 
transferrin. 
dase to remove the sialic acids present on the oligosac- 
charide chain. Figure 4 shows the corresponding mass 
spectra of the intact and desialylated transferrin ob- 
tained by ESI and MALDI/TOF mass spectrometry. In 
ESI (Figure 4a and b) as well in the linear mode 
MALDI (Figure 4c and d), the mass difference between 
the two samples was 1.1-1.2 ku, which corresponds to 
the mass of four sialic acids. In contrast, the reflectron 
mode MALDI spectra of both the native and the desi- 
alylated transferrin resulted in quite similar molecular 
weights (Figure 4e and f). The obtained values corre- 
spond in both cases to the molecular weight of the 
desialylated transferrin. Table 1 gives an overview of 
all measured values. The values obtained by MALDI /  
TOF mass spectrometry in Table 1 are the observed 
singly charged ion masses. The analyses were repeated 
several times and resulted in a reproducibility of about 
0.35% (relative standard deviation) for the LDI 1700 
and 0.1% for the Vision 2000. By a comparison of the 
results in the linear and the reflectron modes, the 
content of the sialic acids can be estimated roughly, as 
discussed later. The average mass difference for the 
native normal transferrin obtained from the two modes 
is 1175 u. This fits quite well with the calculated mass 
of four sialic acids, which is 1165.2 u. Similarly, the 
loading values of sialic acids in the case of carbohy- 
drate-deficient transferrin can be estimated roughly. 
Although the mass accuracy may be low because of 
the detection of the corresponding peak on the shoul- 
der of the intact transferrin signal peak, the average 
mass difference between the carbohydrate-deficient 
transferrin signals in the linear and reflectron modes of 
about 790 u is equivalent to 2.7 sialic acids. 
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Figure 4. Comparison of mass spectra of intact and sialidase- 
treated transferrin obtained by MALDI/TOF mass spectrometry 
in the linear (LDI 1700) and the reflectron mode (Vision 2000) 
and by ESI-MS (TSQ-7000). Electrospray mass pectra nd corre- 
sponding deconvoluted spectra are shown. The analysis was 
performed with microcapillary sample loading. Acetonitrile solu- 
tion was used for elution. (a, b) ESI spectra; (c, d) linear mode 
MALDI/TOF mass pectra; (e, f) reflectron mode MALDI/TOF 
mass spectrometry. (a,c, e) intact ransferrin; (b, d, f) sialidase- 
treated transferrin. 
Discussion 
Serum transferrin precipitated by specific antibodies 
was successfully analyzed by MALDI/TOF and ESI 
mass spectrometry. Immunoprecipitates that contain 
transferrin and its antibody showed several ions by 
MALDI/TOF mass spectrometry, which correspond to 
transferrin, IgG, and other minor components. For ESI- 
MS we first tried to load the immunoprecipitates 
through a conventional infusion pump, but no signifi- 
cant ion signals could be observed. In contrast, the 
spectra of immunoprecipitates analyzed by ESI-MS 
connected irectly to a microcapillary reversed-phase 
column (on-line loading) showed clearly resolved ion 
signals. The better resolution by the on-line loading 
may be caused by the separation of transferrin and 
other proteins as well as the removal of the adducting 
species on the column. The adduct ions may be pro- 
duced by contamination with substances in the glass- 
ware, water, reagents, fused silica, and dust from room 
air that bind to transferrin when loaded through the 
conventional infusion pump. 
The purification procedure of affinity chromatogra- 
phy by using an immobilized specific antibody is rather 
complicated. It is time-consuming to isolate a specific 
antibody by using immobilized protein. For some sub- 
stances it is difficult to obtain a sufficient amount of 
pure antigen to prepare the solid phase column. In 
contrast o affinity chromatography, the immunopre- 
cipitation method does not require isolated specific 
antibody nor, therefore, pure antigen. The method re- 
quires only antiserum that contains a specific antibody 
against the protein to be tested, other antibodies, and 
all other serum components. However, when anti- 
serum against transferrin was mixed with test serum, 
precipitates that were shown to contain only transfer- 
fin and IgG class antibody appeared. During mass 
spectrometry analysis, the signal due to IgG did not 
interfere with that of transferrin. Immunoprecipitation 
is a simple and rapid procedure and we believe it is 
suitable as a clinical laboratory test. 
We analyzed transferrin prepared from patients with 
carbohydrate-deficient glycoprotein (CDG) syndrome. 
In ESI spectra of the maIn peak observed uring mi- 
crocapillary HPLC of immunoprecipitates from a nor- 
mal control and a CDG patient, multiply charged ion 
peaks of normal transferrin were observed and the 
calculated molecular weight was consistent with the 
theoretical value. In the spectra from patient material 
the ion peaks of the subcomponent between the ion 
peaks of the main component were observed and the 
calculated molecular weight was 2.2 ku less than the 
normal transferrin. This value corresponds to that of 
abnormal transferrin from CDG patient sera character- 
ized by Yamashita et al. [7]. In the MALDI spectra of 
immunoprecipitate from CDG patient serum the ion 
peak on the shoulder peak of the normal component is
also 2.2 ku less than the normal molecule. The shoul- 
der peaks also were reported by Wada et al. [10] in 
affinity purified transferrin from a CDG patient. When 
test serum was mixed with normal rabbit serum or 
purified normal immunoglobulin, o precipitate was 
obtained; accordingly no mass spectrometry signals 
were detected. The appearance of carbohydrate-deft- 
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cient transferrin also has been reported in connection 
with regular high alcohol consumption [4]. That study 
revealed that the abnormal transferrin contains re- 
duced proportions of the carbohydrates that constitute 
its terminal trisaccharide (sialic acid, galactose, and 
N-acetylghicosamine). In our MALDI/TOF mass spec- 
trometry analysis the transferrin spectra from heavy 
alcohol drinkers showed additional ions as a low 
mass/charge shoulder on the signal associated with 
normal transferrin. ESI-MS analyses of the same sam- 
ples also revealed the variant molecule with almost the 
same molecular weight as the variant found in CDG 
syndrome patients. Inoue et al. [5] demonstrated by 
conventional chemical methods that transferrin from 
alcohol drinkers contains the molecule that lacks either 
or both of two N-linked disialylated biantermary car- 
bohydrate chains. Our findings are consistent with 
their evidence. 
In MALDI/TOF mass spectrometry, the molecular 
weights obtained by the reflectron mode and the linear 
mode were different for the intact, sialic-acid contain- 
ing transferrin. In the linear mode, it was in better 
agreement with the value achieved by ESI-MS and the 
theoretical value. The average mass difference in spec- 
tra of both modes corresponded to 4 mol of sialic 
acids, which is the actual number per molecule of 
intact transferrin. The observed molecular weight of 
the singly charged ion of intact transferrin measured 
by another eflectron MALDI instrument, he Kompact 
Maldi III, was 78.3-78.8 ku [9], which is very close to 
that obtained by the Vision 2000 in the reflectron 
mode. However, the spectra of the desialylated trans- 
ferrin showed no such mass difference. All these find- 
ings suggest that the bond of the sialic acids to the 
galactose is labile under MALDI conditions. The expla- 
nation of the difference in the molecular weight mea- 
sured by linear and reflectron mode MALDI has been 
discussed [11, 12]. Most probably sufficient energy is 
stored in these bonds upon the desorption-ionization 
process to leave the glycoprotein ions in a metastable 
state. When the ions leave the source region, the sialic 
acids separate from the glycoprotein during flight 
through the field-free drift tube of the TOF mass spec- 
trometer. After this process, termed "post source de- 
cay" [16, 17], the fragment ion will have less kinetic 
energy due to the loss in mass, but will retain its 
velocity (at least to first approximation). Therefore, in a 
linear mode TOF mass spectrometer where no addi- 
tional accelerating fields influence the velocity of the 
ions, these fragments arrive at the detector at the same 
time as intact ions would, which results in a measure- 
ment of the mass of the original molecule ven when it 
has decomposed. In contrast, a reflectron-type TOF 
mass spectrometer responds to the reduced kinetic 
energy of the ions. Here the fragments penetrate less 
deeply into the retarding reflectron field than intact 
ions with the correct kinetic energy; thus they return 
and arrive earlier at the detector. As long as the energy 
deficit is on the order of a few percent, the fragment 
ions can be focused quite correctly to their actual mass 
[18]. Therefore, a comparison between the results in 
both the linear and the reflectron mode can provide 
useful structural information due to an estimation of 
the number of sialic acids on the glycoprotein. 
Immunoprecipitation is a suitable serum protein 
preparation method for mass spectrometry, especially 
for clinical diagnoses of protein abnormality. Poly- 
clonal as well as monoclonal antibodies against many 
kinds of protein are commercially available. We be- 
lieve that this procedure will provide a powerful strat- 
egy for the analysis of various kinds of protein in 
plasma, urine, and other body fluids. 
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